Local PBM market is dwindling, AMA finds
The nation's 6 largest PBMs control 96% of the market share, and local PBMs are rapidly consolidating, according to the American Medical Association.
Stay updated with breaking news from Magellan Rx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The nation's 6 largest PBMs control 96% of the market share, and local PBMs are rapidly consolidating, according to the American Medical Association.
Representatives from Magellan Rx Management provided a detailed overview of current treatment options in ophthalmology and the impact that biosimilars could have during a session at AMCP 2023.
Jan 13, 2021 1:13pm Executive leaders at NeuroFlow include (l to r) Adam Pardes, COO and co-founder, Christopher Molaro, CEO and co-founder; and Julia Kastner, vice president of product. (NeuroFlow) Behavioral health startup NeuroFlow secured a $20 million series B investment backed by managed care company Magellan Health. NeuroFlow’s platform aggregates mental health data and builds comprehensive patient profiles, which care teams can use to identify patterns and treatment decisions. The company's technology facilitates healthcare management for patients in between traditional office-bas...